These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6263540)

  • 41. [Captopril in the therapy of resistant hypertension. A multicenter study].
    Mion Júnior D; Silva HB; Marcondes M
    Arq Bras Cardiol; 1983 May; 40(5):363-7. PubMed ID: 6360101
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical and diagnostic evaluation of the treatment of systemic arterial hypertension with captopril and hydrochlorothiazide].
    Caporicci D; Achilli L; Pepi R; Mori A
    Clin Ter; 1985 Apr; 113(2):105-10. PubMed ID: 3893866
    [No Abstract]   [Full Text] [Related]  

  • 43. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hypertensive crisis. Treatment with captopril after failure with a diuretic. Multicenter study].
    Saragoça M; Ribeiro AB; Ramos OL
    Arq Bras Cardiol; 1982 May; 38(5):415-9. PubMed ID: 6762867
    [No Abstract]   [Full Text] [Related]  

  • 45. [Captopril in the control of essential arterial hypertension in diabetic subjects].
    Ricci PD; Fazzi L; Ricci F
    Clin Ter; 1985 Apr; 113(1):33-8. PubMed ID: 3893865
    [No Abstract]   [Full Text] [Related]  

  • 46. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Validity of a fixed atenolol/hydrochlorothiazide/amiloride combination (100/25/2.5 mg) in the therapy of essential arterial hypertension].
    Salvadeo A; Villa G; Segagni S; Moroni G; Poggio F
    Minerva Cardioangiol; 1988 Mar; 36(3):109-13. PubMed ID: 3412613
    [No Abstract]   [Full Text] [Related]  

  • 48. [Captopril (oral inhibitor of angiotensin I converting-enzyme) in arterial hypertension].
    Simonetti BM; Manzi M; Feriozzi S; Pierucci A
    Clin Ter; 1982 Jul; 102(1):67-83. PubMed ID: 6754215
    [No Abstract]   [Full Text] [Related]  

  • 49. Captopril.
    Ram CV
    Arch Intern Med; 1982 May; 142(5):914-6. PubMed ID: 6282230
    [No Abstract]   [Full Text] [Related]  

  • 50. Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration.
    Lindroos M; Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):643-5. PubMed ID: 6396239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):175-80. PubMed ID: 3030978
    [No Abstract]   [Full Text] [Related]  

  • 52. [Converting enzyme inhibitors in the therapy of primary arterial hypertension].
    Di Veroli C; Bossini A; Amoroso A
    Recenti Prog Med; 1985 May; 76(5):269-71. PubMed ID: 2992055
    [No Abstract]   [Full Text] [Related]  

  • 53. The use of captopril in the management of cardiac failure.
    Cleland JG; Dargie HJ; Robertson JI; Ball SG; Hodsman GP
    Scott Med J; 1984 Apr; 29(2):129-30. PubMed ID: 6099613
    [No Abstract]   [Full Text] [Related]  

  • 54. Therapeutic effect of captopril once-daily in essential hypertension.
    Gil V; Lahera V; Beneyto MC; Lopez-Vidriero E; Rodriguez FJ
    Bibl Cardiol; 1987; (42):152-5. PubMed ID: 2820374
    [No Abstract]   [Full Text] [Related]  

  • 55. Increase of serum and membrane-bound angiotensin-converting enzyme by captopril (SQ 14225) treatment.
    Grönhagen-Riska C; Forslund T; Hortling L; Fyhrquist F
    Acta Med Scand Suppl; 1983; 677():101-4. PubMed ID: 6322528
    [No Abstract]   [Full Text] [Related]  

  • 56. [Validity and effectiveness of a pre-constituted captopril-hydrochlorothiazide combination in a single daily dose].
    Carnovali M; Crespi E; Panozzo M; Missaglia A; Ponti G
    Clin Ter; 1986 Oct; 119(2):111-7. PubMed ID: 3539467
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical and therapeutic experience in elderly patients with arterial hypertension].
    Del Prato C; Triacca R; Gramenzi S; Astorri E
    Clin Ter; 1987 Feb; 120(4):303-7. PubMed ID: 2953530
    [No Abstract]   [Full Text] [Related]  

  • 58. Specific patient challenge: the elderly hypertensive patient.
    Tuck ML
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):187-9. PubMed ID: 3549642
    [No Abstract]   [Full Text] [Related]  

  • 59. [Physiopathological basis for a tailored management of essential hypertension].
    Albertazzi A; Del Rosso G; Di Paolo B; Spisni C; Palmieri PF; Cappelli P; Di Vito R
    Clin Ter; 1981 Feb; 96(4):359-69. PubMed ID: 6111413
    [No Abstract]   [Full Text] [Related]  

  • 60. A long-term follow-up of patients with essential hypertension treated with captopril.
    Ohman P; Aurell M; Asplund J; Conradsson T; Delin K; Forslund T; Fyhrquist F; Frithz G; Herlitz H; Karlberg B
    Acta Med Scand; 1984; 216(1):53-6. PubMed ID: 6385634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.